ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025
First-pass efficacy with simplicity: Macrowire-only direct aspiration technique in posterior circulation mechanical thrombectomy.
Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundDuring mechanical thrombectomy for large-vessel occlusions, a ledge effect makes navigating the aspiration catheters (ACs) to the occlusion difficult. New large-bore macrowires minimize this while ensuring flexibility and navigational control. We evaluated the technical feasibility of delivering large-bore ACs to posterior circulation occlusions.MethodsThis retrospective multicenter study evaluated patients treated for posterior circulation strokes with adjunct-free macrowire-only direct aspiration first-pass technique (MO-ADAPT) using 0.024- and 0.035-in macrowires between October 2022 and December 2024. Primary outcomes included successful catheter delivery, successful MO-ADAPT (i.e. adjunct-free catheter delivery and successful clot aspiration), and first-pass reperfusion (i.e. modified thrombolysis in cerebral infarction (mTICI) score ≥ 2b after one MO-ADAPT pass).ResultsAmong 42 included patients (mean age 68.3 ± 15.4 years), adjunct-free delivery of ACs to the occlusion using macrowires only was successful in 95.2%. An MO-ADAPT primary approach achieved successful reperfusion in 81.0%, with first-pass reperfusion in 54.8%. Among patients with successful AC delivery, the aspiration success rate was 85.0%. Final mTICI scores of 3, 2c, and 2b after all procedures were seen in 78.6%, 14.3%, and 4.8%, respectively, regardless of thrombectomy method. No vascular complications were observed, and postprocedural intracranial hemorrhage and distal emboli occurred in 2.4% each. A favorable clinical outcome at 90 days was observed in 33.3% of cases. Multivariable analysis showed that underlying intracranial atherosclerotic disease was a negative predictor of both MO-ADAPT success and first-pass reperfusion; no factors predicted AC delivery success.ConclusionIn this retrospective series, MO-ADAPT appeared to be technically feasible for treating posterior circulation strokes, with promising procedural results and a low complication rate. Observed failures were mainly associated with underlying intracranial atherosclerotic disease requiring stent retriever-assisted mechanical thrombectomy. Given the limited sample size and study design, further studies, ideally with larger cohorts and comparative designs, are necessary to clarify the relative safety, efficacy, and cost effectiveness of MO-ADAPT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.